购物车
您的购物车当前为空
FTISADTSK acetate is a stable endogenous signature peptide sourced from Trastuzumab, which can be monitored using selected reaction monitoring (SRM)[1].
FTISADTSK acetate is a stable endogenous signature peptide sourced from Trastuzumab, which can be monitored using selected reaction monitoring (SRM)[1].
| 规格 | 价格 | 库存 | 数量 |
|---|---|---|---|
| 5 mg | ¥ 1,992 | 待询 | |
| 10 mg | ¥ 3,369 | 待询 |
| 产品描述 | FTISADTSK acetate is a stable endogenous signature peptide sourced from Trastuzumab, which can be monitored using selected reaction monitoring (SRM)[1]. |
| 密度 | no data available |
| Sequence | H-Phe-Thr-Ile-Ser-Ala-Asp-Thr-Ser-Lys-OH |
| Sequence Short | FTISADTSK |
| 存储 | |
| 溶解度信息 | H2O: 50 mg/mL, Sonication is recommended. |
对于不同动物的给药剂量换算,您也可以参考 更多